Jw Holdings (096760) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jw Holdings (096760) has a cash flow conversion efficiency ratio of 0.118x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩66.90 Billion ≈ $45.34 Million USD) by net assets (₩567.12 Billion ≈ $384.33 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Jw Holdings for the company's overall valuation and market capitalisation.
Jw Holdings - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Jw Holdings's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Jw Holdings Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jw Holdings ranked by their cash flow conversion efficiency. Explore 096760 cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
AGILYX ASA NK -02
F:5NQ
|
N/A |
|
Doosan Co Ltd
KO:000157
|
0.010x |
|
Guolian Securities Co. Ltd
F:34V
|
0.259x |
|
Scicom MSC Bhd
KLSE:0099
|
0.047x |
|
RCI Hospitality Holdings Inc
NASDAQ:RICK
|
0.051x |
|
NRC Group ASA
OL:NRC
|
0.048x |
|
Onward Medical N.V.
BR:ONWD
|
-0.366x |
|
GENFIT S.A. ADR/1 EO-25
F:XUPB
|
N/A |
Annual Cash Flow Conversion Efficiency for Jw Holdings (2007–2024)
The table below shows the annual cash flow conversion efficiency of Jw Holdings from 2007 to 2024. View latest Jw Holdings stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩521.39 Billion ≈ $353.34 Million |
₩97.89 Billion ≈ $66.34 Million |
0.188x | -41.70% |
| 2023-12-31 | ₩348.75 Billion ≈ $236.35 Million |
₩112.32 Billion ≈ $76.12 Million |
0.322x | +2.78% |
| 2022-12-31 | ₩333.26 Billion ≈ $225.85 Million |
₩104.43 Billion ≈ $70.77 Million |
0.313x | -12.89% |
| 2021-12-31 | ₩304.82 Billion ≈ $206.57 Million |
₩109.64 Billion ≈ $74.30 Million |
0.360x | +10.92% |
| 2020-12-31 | ₩334.97 Billion ≈ $227.00 Million |
₩108.62 Billion ≈ $73.61 Million |
0.324x | +15.54% |
| 2019-12-31 | ₩351.62 Billion ≈ $238.29 Million |
₩98.68 Billion ≈ $66.88 Million |
0.281x | -42.51% |
| 2018-12-31 | ₩401.00 Billion ≈ $271.75 Million |
₩195.76 Billion ≈ $132.67 Million |
0.488x | +1640.33% |
| 2017-12-31 | ₩374.73 Billion ≈ $253.95 Million |
₩10.51 Billion ≈ $7.12 Million |
0.028x | +126.65% |
| 2016-12-31 | ₩277.59 Billion ≈ $188.12 Million |
₩-29.21 Billion ≈ $-19.80 Million |
-0.105x | -18.65% |
| 2015-12-31 | ₩270.31 Billion ≈ $183.18 Million |
₩-23.98 Billion ≈ $-16.25 Million |
-0.089x | -9.45% |
| 2014-12-31 | ₩211.94 Billion ≈ $143.63 Million |
₩-17.18 Billion ≈ $-11.64 Million |
-0.081x | +64.60% |
| 2013-12-31 | ₩236.03 Billion ≈ $159.95 Million |
₩-54.03 Billion ≈ $-36.62 Million |
-0.229x | -5557.31% |
| 2012-12-31 | ₩205.46 Billion ≈ $139.24 Million |
₩861.85 Million ≈ $584.07K |
0.004x | -89.87% |
| 2010-12-31 | ₩192.45 Billion ≈ $130.42 Million |
₩7.97 Billion ≈ $5.40 Million |
0.041x | +6.94% |
| 2008-12-31 | ₩213.99 Billion ≈ $145.02 Million |
₩8.28 Billion ≈ $5.61 Million |
0.039x | -48.81% |
| 2007-12-31 | ₩214.73 Billion ≈ $145.52 Million |
₩16.24 Billion ≈ $11.01 Million |
0.076x | -- |
About Jw Holdings
JW Holdings Corporation, together with its subsidiaries, operates as a healthcare company in South Korea, the United States, Japan, China, and internationally. The company offers amino acid solutions, gastrointestinal agents, wound care, eye care, liver disease treatment, cold medicine, API, oral and topical analgesic, and other miscellaneous pharmaceutical products. It also offers hairdye, hair … Read more